Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors

Clinical trial NCT07001592 · RECRUITING

Trial details

NCT number: NCT07001592
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Gastric Neoplasms Esophageal Cancer Liver Cancer Liver Metastasis MSS-CRC MSS Gastric Adenocarcinoma Peritoneal Cancer Peritoneal Carcinoma Peritoneal Metastases MSI-H Gastric Cancer

Start date: 2025-05-06
Primary completion: 2028-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.